Intrommune's lead product, INT301, is expected to be a safe, effective and convenient therapy for patients who suffer from peanut allergy
. There is no FDA-approved treatment for peanut allergy
or any other food allergy.
Researchers suggest that in order to prevent peanut allergy
, peanut protein (such as peanut butter or powdered puff) may be introduced at home for most babies between 4 and 6 months as one of the first foods.
Gupta also showed that peanut allergy
was reported most often among white children (47.7%) and children from households with an annual income of $50,000-$99,999 (41.7%).
is persistent in the majority of cases, and only outgrown in ~20% of patients.
"Until recently there has been nothing to offer peanut allergy
suffers other than education around avoidance and self-treatment of reactions."
Reportedly, ASIT biotech now has three product candidates selected on the ASIT+ platform for allergies with the highest prevalences, namely allergic rhinitis caused by grass pollen, peanut allergy
and house dust mite allergy.
A randomized, controlled trial (Learning Early About Peanut Allergy
; LEAP, published in 2015) demonstrated that early introduction of peanut-containing food (ie, at 4 months to < 11 months of age) in infants at high risk for peanut allergy
(defined as presence of severe atopic dermatitis, egg allergy, or both) resulted in a significantly lower risk of developing peanut allergy
by age 60 months compared with peanut avoidance.
THE RESULTS: Children who avoided peanut containing foods had a much higher incidence of having a peanut allergy
compared to children who had consistently and frequently consumed peanut products from a young age.
Previous guidelines published in 2010 did not provide specific treatment strategies for peanut allergies because of a lack of research, but the significant results of the Learning Early About Peanut Allergy
(LEAP) study suggested that early exposure to peanut-containing foods reduces the risk of developing allergies.
To avoid potentially life-threatening allergic reactions, people with peanut allergy
must be vigilant about the foods they eat and the environments they enter, which can be very stressful, said NIAID Director Anthony S.
Global Markets Direct's, 'Peanut Allergy
- Pipeline Review, H1 2016', provides an overview of the Peanut Allergy
The increase in allergy to peanut in westernised countries  has sparked widespread interest in peanut allergy
. Recent progress has been made in identifying risk factors for peanut allergy
, such as epithelial barrier defects leading to epicutaneous sensitisation by peanut protein.